Skip to main content

Table 2 SNRPN and snoRNA expression analysis with quantitative RT-PCR

From: Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome

Amplification product

PWS

Normal control

t-PWS (4;15)

PWS triplication

t-PWS intron 2

t-PWS (4;15)

 

LCL

LCL

LCL

LCL

FB

FB

SNURF Ex 2

0.0001

0.53

0.54

2

0.002

0.56

SNURF Ex 3

0.0002

1.1

1.43

6.4

0.0004

0.56

HBII-437

0.00003

0.86

1.13

4.9

0.00008

0.1

SNRPN 14/15

0.0013

4.7

4.91

17.23

-

-

SNRPN 19/20a

0.005

1.34

0.003

4.7

0.007

0.007

HBII-438

0.03

1.5

0.02

6.2

0.07

0.07

PWCR1/HBII-85

0.03

3.7

0.02

16.8

0.04

0.06

  1. Sample identification: PWS: PWS with an IC microdeletion (patient E in [5]); t(4;15) PWS: the PWS case reported here; PWS-triplication: intrachromosomal triplication of the PWS region [33]; t-PWS intron 2: previously reported PWS case with t(4;15)(q27;q11.2) and breakpoint in SNRPN intron 2 [26, 27]; LCL, lymphoblastoid cell line, FB, fibroblast strain. The numbers represent the ratio of target product to GAPDH control product.